« FDA seeks outside review of Ketek antibiotic on December 14 and 15 | Main | Ketek Drug Maker Continues Discussion with FDA »

Ketek: More safety warnings will affect sales

The antibiotic Ketek is likely to face more safety warnings. Sanofi-Aventis’ stock for the sales of Ketek will most likely be hurt in the United States and Europe. (New Ratings)

Posted by Michael Monheit on December 13, 2006 07:59 AM |

TrackBack

TrackBack URL for this entry:
http://blogs.legalview.com/mt-admin/mt-tb.cgi/754

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)